Moreover, a comparison of the number of animals with unhealed defects (all controls) or healed defects (complete bony continuity across the defect site) showed that besides pentadecapeptide intramuscular application for 14 days (i.e., local application of bone marrow or autologous cortical graft), also following other pentadecapeptide BPC-157 regimens (local application, or intermittent intramuscular administration), the number of animals with healed defect was increased
Toxicity from Contaminated Products: The side effects often come not from the peptide itself, but from endotoxins and heavy metals found in unregulated research-grade vials
Digestive Support: As a naturally occurring peptide in the gut, BPC157 may help maintain gastrointestinal lining health and support healing of ulcers or inflammatory damage
They are: Contaminated or mislabelled compounded products research-grade vs pharmaceutical-grade manufacturing matters enormously Incorrect dosing without clinical oversight, patients routinely underdose (no effect) or overdose (unknown risk) Drug interactions particularly relevant if you are on GLP-1 therapy, immunosuppressants, or anti-inflammatory medications
One of only three published human studies on BPC-157, this open-label trial investigated intra-articular injections for knee pain